Overview

Ghana

Kenya

Lesotho

Rwanda

South Africa

Swaziland

Tanzania

Zambia

0

Million Dollars Raised

In the nearly ten years since (RED)’s launch, it has generated more than $365 million to support The Global Fund’s work.

0

Million People Impacted

The money is used to finance HIV/AIDS grants in Ghana, Kenya, Lesotho, Rwanda, South Africa, Swaziland, Tanzania, and Zambia, impacting the lives of 70 million people.

Ghana

National Population
0
People Living with HIV
0
Decline in MTCT since 2005 (%)
0
% of HIV+ Pregnant women on treatment in 2015
0

(RED) Impact

0

Million dollars disbursed, to date, to HIV/AIDS Global Fund grants in Ghana

0

Million lives impacted by (RED)-supported Global Fund grants

Kenya

National Population
0
People Living with HIV
0
Decline in MTCT since 2005 (%)
0
% of HIV+ Pregnant women on treatment in 2015
0

(RED) Impact

0

Million dollars disbursed, to date, to HIV/AIDS Global Fund grants in Kenya

0

Million lives impacted by (RED)-supported Global Fund grants

Lesotho

National Population
0
People Living with HIV
0
Decline in MTCT since 2005 (%)
0
% of HIV+ Pregnant women on treatment in 2015
0

(RED) Impact

0

Million dollars disbursed, to date, to HIV/AIDS Global Fund grants in Lesotho

0

Million lives impacted by (RED)-supported Global Fund grants

Rwanda

National Population
0
People Living with HIV
0
Decline in MTCT since 2005 (%)
0
% of HIV+ Pregnant women on treatment in 2015
0

(RED) Impact

0

Million dollars disbursed, to date, to HIV/AIDS Global Fund grants in Rwanda

0

Million lives impacted by (RED)-supported Global Fund grants

South Africa

National Population
0
People Living with HIV
0
Decline in MTCT since 2005 (%)
0
% of HIV+ Pregnant women on treatment in 2015
0

(RED) Impact

0

Million dollars disbursed, to date, to HIV/AIDS Global Fund grants in South Africa

0

Million lives impacted by (RED)-supported Global Fund grants

Swaziland

National Population
0
People Living with HIV
0
Decline in MTCT since 2005 (%)
0
% of HIV+ Pregnant women on treatment in 2015
0

(RED) Impact

0

Million dollars disbursed, to date, to HIV/AIDS Global Fund grants in Swaziland

0

Million lives impacted by (RED)-supported Global Fund grants

Tanzania

National Population
0
People Living with HIV
0
Decline in MTCT since 2005 (%)
0
% of HIV+ Pregnant women on treatment in 2015
0

(RED) Impact

0

Million dollars disbursed, to date, to HIV/AIDS Global Fund grants in Tanzania

0

Million lives impacted by (RED)-supported Global Fund grants

Zambia

National Population
0
People Living with HIV
0
Decline in MTCT since 2005 (%)
0
% of HIV+ Pregnant women on treatment in 2015
0

(RED) Impact

0

Million dollars disbursed, to date, to HIV/AIDS Global Fund grants in Zambia

0

Million lives impacted by (RED)-supported Global Fund grants

Preventing the mother-to-child
transmission of HIV

Watch Connie's Story

(RED) supports The Global Fund HIV/AIDS grants in eight countries with a goal of virtually eliminating transmission of the virus from moms to their babies.

But many of you have rightfully asked, “How does this exactly work?” It’s a miracle of modern medical technology that we’re able to prevent the mother-to-child transmission of HIV (PMTCT).

To help you understand, here is how it works:

An HIV-positive mother can pass HIV on to her baby any time during pregnancy, labor, delivery and breastfeeding, so the transmission of the virus must be blocked at each stage. Current World Health Organization guidelines recommend that HIV-positive pregnant mothers should go on a triple-drug regimen of antiretroviral medication (ARVs) through pregnancy, delivery and breastfeeding. Ideally, the mothers themselves will also remain on treatment once breastfeeding has concluded, for their own health.

ARVs work to keep HIV from growing and multiplying within the human body. With access to ARVs, people living with HIV can not only lead healthy and productive lives, but they can pass on healthy lives to their unborn children.

As soon as the infant is born, the baby should be given nevirapine daily for six weeks. Based on her individual circumstance, the mother should receive counseling and guidance from her healthcare provider on whether the infant should be formula-fed or breastfed.

If the mother is to breastfeed, it is recommended that she do so exclusively for six months while continuing to take her ARVs. After six months, the mother can introduce appropriate complementary foods, and continue breastfeeding for the first 12 months of the child’s life.

Mothers who adhere to this regimen can reduce the risk of transmission of HIV to their babies to less than 5%. These prevention guidelines have evolved over the years as scientists have learned more about how to most effectively reduce the risk of transmission while also working to minimize drug resistance for our most effective treatment tools.

Act Now

While there have been significant reductions in the spread and transmission of HIV, there are still 400 babies being born every day with a preventable virus.

We must act now to get that number close to zero.

Shop (RED) Products

When shopping (RED) products, manufacturers send a contribution directly to the Global Fund.

Shop (RED)
Make a Donation

Support (RED) and know that 100% of your donation goes to work on the ground.

Donate
Get Involved

Want to join the team at (RED)? Check out our positions available.

Careers